| HOME >> MEDICINE >> TECHNOLOGY |
Figure 27: Pharmaceutical Market, India, Gastrointestinal Market Revenue ($m), 2005–2010 51
Figure 28: Pharmaceutical Market, India, Diabetes Market Revenue ($m), 2005–2010 53
Figure 29: Pharmaceutical Market, India, Central Nervous System Market Revenue ($m), 2005–2010 55
Figure 30: Pharmaceutical Market, India, Respiratory Market Revenue ($m), 2005–2010 57
Figure 31: Pharmaceutical Market, India, Dermatology Market Revenue ($m), 2005–2010 59
Figure 32: Pharmaceutical Market, India, Oncology Market Revenue ($m), 2005–2010 61
Figure 33: Pharmaceutical Market, India, Number of M&A Deals, 2007–2012 63
Figure 34: Pharmaceutical Market, India, M&A Deals, Deals by Value (%), 2007–2012 64
Figure 35: Pharmaceutical Market, India, Number of Licensing Deals, 2007–2012 65
Figure 36: Pharmaceutical Market, India, Licensing Deals, Deals by Value (%), 2007–2012 65
Figure 37: Pharmaceutical Market, India, Number of Partnership Deals, 2007–2012 66
Figure 38: Pharmaceutical Market, India, Partnership Deals, Deals by Value (%), 2007–2012 66
Figure 39: Pharmaceutical Market, India, Novartis Arogya Parivar Marketing Mix, 2012 68
Figure 40: Pharmaceutical Market, India, Novartis Arogya Parivar, Factsheet, 2012 69
Figure 41: Pharmaceutical Market, India, Mankind Sales Strategies, 2012 71
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |